MyFinsight
Home
About
Contact
rckt: the income statement
Download
Download image
Net loss
-$50,332K
(24.56%↑ Y/Y)
Accretion of discount on
investments, net
$1,679K
(-9.19%↓ Y/Y)
Interest and other
income, net
$709K
(-46.57%↓ Y/Y)
Interest expense
$473K
(0.42%↑ Y/Y)
Loss from operations
-$52,247K
(24.74%↑ Y/Y)
Total operating
expenses
$52,247K
(-24.74%↓ Y/Y)
Restructuring
-$172K
General and
administrative
$18,351K
(-32.31%↓ Y/Y)
Research and development
$34,068K
(-19.49%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ROCKET PHARMACEUTICALS, INC. (RCKT)
ROCKET PHARMACEUTICALS, INC. (RCKT)